Skip to content
Topics/Dermatology

Generalized Skin Disorders

Pro
Audio podcast
Listen on the go — with live captions.
Infographic
High-yield one-pager.
Slide deck
Tight, illustrated review.
MCQs
15 questions available
Easy · 6
Medium · 8
Hard · 1

Case simulations

Learn this topic by working through ED cases step-by-step.

medium
~15 min
Pro
43F with a well-demarcated facial rash

A 43-year-old female presents to the emergency department with a gradually worsening facial rash and orange-peel skin changes.

hard
~15 min
Pro
65M with unilateral painful facial blisters

A 65-year-old male presents with a painful, unilateral blistering rash on his forehead extending to the tip of his nose.

medium
~15 min
Pro
67F with progressive lip swelling and respiratory distress

A 67-year-old female presents with progressive lip swelling, facial edema, and hypoxia 3 months after starting lisinopril.

Mind map

Summary

1. THE 2-MINUTE PHYSIOLOGY

Generalized, life-threatening skin disorders represent a spectrum of severe immunologic or toxin-mediated reactions that critically compromise the skin's barrier function. Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) exist on a shared disease spectrum characterized by severe epidermal and mucosal membrane necrosis, leading to full-thickness sloughing. These are most commonly idiosyncratic hypersensitivity reactions triggered by medications such as sulfonamides, anticonvulsants, and allopurinol. Erythema Multiforme (EM) is a distinct type 4 T-cell–mediated immune response driven primarily by antigens, most notably infections like Herpes Simplex Virus (HSV) or Mycoplasma pneumoniae. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) is a severe systemic reaction characterized by diffuse rash, eosinophilia, and multiorgan failure, typically presenting two to three months after initiating an offending medication. Conversely, Staphylococcal Scalded Skin Syndrome (SSSS) is an infectious toxidrome caused by an exotoxin produced by Staphylococcus aureus that cleaves the outer layers of the epidermis, causing it to slide off with minimal pressure.

2. THE BEDSIDE ACTION PLAN

  • Airway & Resuscitation: Early endotracheal intubation must be considered for patients with SJS, TEN, or DRESS who exhibit significant mucous membrane involvement, pneumonitis, altered mental status, or shock.
  • Fluid Management: Severe exfoliative dermatoses generate massive insensible fluid losses; aggressive intravenous fluid resuscitation similar to burn management protocols is mandatory, targeting a urine output of 1 to 2 mL/kg/hr.
  • Trigger Elimination: The absolute most critical pharmacological step is the immediate discontinuation of any newly started or potential offending medications.
  • Targeted Pharmacotherapy:
  • SSSS: Requires prompt IV anti-staphylococcal antibiotics, such as Nafcillin, Oxacillin, or Vancomycin/Clindamycin if MRSA is suspected.
  • SJS/TEN: Treatment is primarily supportive wound care; while high-dose intravenous immune globulin (IVIG) or tumor necrosis factor inhibitors (Etanercept) may provide benefit, systemic corticosteroids are not supported and may actually increase morbidity and mortality.
  • DRESS: Avoid empiric antibiotics; severe cases with organ involvement require systemic steroids, such as methylprednisolone 125 mg IV every 6 hours.
  • EM: Supportive care with oral antihistamines and topical steroids; systemic corticosteroids are not routinely indicated as they can prolong the disease course and increase recurrence rates.

3. THE DIAGNOSTIC GRID

  • The Life Threats: The differential for erythroderma and severe desquamation includes SJS, TEN, SSSS, DRESS, and Toxic Shock Syndrome (TSS).
  • Systemic Workup: Multiorgan involvement is a hallmark of these severe conditions; assess for hepatic and renal failure, disseminated intravascular coagulation (DIC), and profound hypotension. DRESS syndrome specifically requires evaluation for severe transaminitis, acute kidney injury, and profound hematologic eosinophilia.
  • Differentiating Features: The presence of severe allodynia (pain from non-painful stimuli) strongly points towards SJS, TEN, and SSSS.

4. THE VISUAL BOARD

  • SJS & TEN: Initially presents as erythematous macules with purpuric centers, rapidly progressing to flaccid vesicles, bullae, and widespread full-thickness skin sloughing. It features prominent involvement of multiple mucous membranes (pharyngeal, ocular, and genital).
  • Erythema Multiforme Major: Characterized by symmetric, diffuse red "targetoid" lesions consisting of a papule or vesicle surrounded by an erythematous halo with central clearing. The eruption is typically acral, affecting the extensor surfaces, palms, and soles.
  • SSSS: Presents with a sudden-onset diffuse, tender erythroderma that progresses to flaccid bullae and large sheets of desquamation, resembling a severe hot-water scald. Critically, SSSS causes crusting around the eyes and mouth but spares the intraoral mucosal surfaces.
  • DRESS: Presents with a diffuse, fine, erythematous maculopapular (morbilliform) eruption and is classically accompanied by prominent facial edema and lymphadenopathy.

5. THE SCORING MATRIX

  • The Rule of Nines: Emergency clinicians must utilize the burn "Rule of Nines" to accurately estimate the percentage of total body surface area (BSA) involved in disorders with widespread distribution.
  • SJS/TEN Classification Spectrum: The specific diagnosis is dictated by the percentage of epidermal detachment: SJS involves <10% BSA; SJS/TEN overlap involves 10% to 30% BSA; and TEN involves >30% BSA detachment.
  • Erythroderma Threshold: Redness of the skin involving >90% of the body surface area is defined as diffuse erythroderma and constitutes an absolute dermatologic emergency.

6. THE DANGER ZONE

  • The "Incomplete Exam" Trap: Failing to fully undress the patient in a well-lit room and neglecting to inspect hidden areas like the groin, axilla, scalp, and all mucosal surfaces will result in missed critical diagnostic clues.
  • The SSSS vs. TEN Trap: Confusing Staphylococcal Scalded Skin Syndrome with Toxic Epidermal Necrolysis can lead to fatal management errors; TEN involves the mucous membranes, whereas SSSS characteristically spares them.
  • The Corticosteroid Trap: Administering systemic corticosteroids for routine Erythema Multiforme is a major cognitive error, as it has been shown to increase recurrence rates upon cessation and prolong the overall disease course.

7. MCQ MASTERCLASS

  • Buzzword: "Targetoid" or "iris" lesions with central clearing heavily favor a diagnosis of Erythema Multiforme.
  • Buzzword: "Positive Nikolsky sign" (where the top layers of the epidermis slip off with minimal lateral pressure) is the hallmark physical exam finding for TEN, SJS, and SSSS.
  • Buzzword: A patient presenting with "eosinophilia" and "transaminitis" several weeks after starting a new anticonvulsant is the classic presentation for DRESS syndrome.
  • Distractor Trap: An exam question may offer empiric antibiotics as a treatment option for a patient with severe mucosal sloughing (SJS/TEN). Antibiotics are indicated for bacterial toxidromes like SSSS and TSS, but should not be given prophylactically for SJS, TEN, or DRESS.

8. THE BOARDROOM SCRIPT

"This is a highly toxic-appearing patient presenting with extensive erythroderma, severe allodynia, and a positive Nikolsky sign. My primary survey reveals an intact but threatened airway; I am prepared to secure it early given the marked oropharyngeal mucosal sloughing. The patient has been completely disrobed and examined under optimal lighting; we note full-thickness epidermal detachment covering approximately 40% of their body surface area, calculated via the Rule of Nines, which firmly categorizes this as Toxic Epidermal Necrolysis. I have immediately discontinued all home medications, particularly their recently prescribed sulfonamide. Aggressive fluid resuscitation is underway utilizing burn management protocols, targeting a urine output of 1 to 2 mL/kg/hr. We are withholding systemic corticosteroids, administering viscous lidocaine for mucosal pain, and I am actively consulting intensivists and dermatology to arrange for emergent transfer to a regional burn center for definitive multidisciplinary care."